TABLE 4.
Survival status of 44 COVID‐19 patients in the experimental group and the control group
| FAS | PPS | |||||
|---|---|---|---|---|---|---|
| Survival status | Experimental group (N = 26) | Control group (N = 18) | P | Experimental group (N = 24) | Control group (N = 18) | P |
| Survival, n (%) | 24 (92.31) | 12 (66.67) | .048* | 23 (95.83) | 12 (66.67) | .031* |
| Death, n (%) | 2 (7.69) | 6 (33.33) | 1 (4.17) | 6 (33.33) | ||
Note.
*
Represents significant difference (P < .05); FAS, full analysis set; PPS, per protocol set; “n” represents number; P value represents the survival rate of COVID‐19 patients in the experimental group and the control group based on FAS and PPS analysis in the entire period.